Rebeca Arroyo Hornero

6PUBLICATIONS
35CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 05, 2025
Publisher Correction: TNF and type I interferon crosstalk controls the fate and function of plasmacytoid dendritic cells.

Rebeca Arroyo Hornero, Raul A Maqueda-Alfaro, Miguel A Solís-Barbosa

|Aug 12, 2025
TNF and type I interferon crosstalk controls the fate and function of plasmacytoid dendritic cells.

Rebeca Arroyo Hornero, Raul A Maqueda-Alfaro, Miguel A Solís-Barbosa

|Jul 06, 2023
Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses.

Fernando Bandeira Sulczewski, Raul A Maqueda-Alfaro, Marcela Alcántara-Hernández

|Jun 09, 2023
Rapid recruitment and IFN-I-mediated activation of monocytes dictate focal radiotherapy efficacy.

Sirimuvva Tadepalli, Derek R Clements, Sanjana Saravanan

|Jul 16, 2020
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.

Rebeca Arroyo Hornero, Christos Georgiadis, Peng Hua

Pageof 1